Yokogawa Announces Synaptic Business Automation(TM) Concept for Industrial Automation and Control Business
Yokogawa Electric Corporation (TOKYO:6841) announces Synaptic Business Automation(TM), a new industrial automation and control business concept that expresses the company’s commitment to working with its customers to sustain their creation of corporate value. Based on the ideals expressed in the Synaptic Business Automation concept, Yokogawa will help companies achieve a transformation in how they conduct their business.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171105005001/en/
Creation of value through Synaptic Business Automation for profitable and sustainable growth (Graphic: Yokogawa Electric Corporation)
A Closer Look at Synaptic Business Automation
Manufacturers
face a variety of challenges today, ranging from volatile shifts in the
prices of crude oil and other raw materials and stiffening environmental
and safety regulations to structural changes in their industries. To
remain competitive, they must have the agility to adapt quickly to
change.
To guide its efforts to assist companies in meeting such challenges, Yokogawa adheres to a vision statement that reads, “Through ‘Process Co-Innovation,’ Yokogawa creates new value with its clients for a brighter future.” We help companies improve efficiency and profitability by getting their various business units to work together more effectively and by eliminating barriers that impede the flow of information and goods throughout the supply chain and between companies.
As the Internet of Things gains traction, a digitalization of processes is underway whereby the use of big data and artificial intelligence is yielding valuable insights needed to make business decisions. The Synaptic Business Automation concept clearly expresses Yokogawa’s commitment to using the latest information technologies and its decades of experience with plant management and industrial processes, portfolio of automation solutions, and consulting expertise to help its customers transform their businesses.
The Synaptic Business Automation concept takes its name from the synapse, a structure in the nervous system that plays a role in the transfer of signals to other parts of the human body. Synaptic Business Automation expresses an ideal state for a business whereby the synthesizing of data, systems, organizations, knowledge, and supply chains adds value and strengthens competitiveness. The linked data on manufacturing processes, plant operations, human resources, and supply chains can be organized, integrated, controlled, broken down, and analyzed to yield insightful decisions at various levels in the organization, from operations in the field to corporate management.
Ways in which Synaptic Business Automation creates corporate value for our customers:
-
Resilient operation
Adapt more flexibly to changes in such areas as health, safety, security and the environment (HSSE), organizational optimization, and regulatory compliance. -
Optimized production
Optimize the total expenditure (TOTEX) components of capital expenditure (CAPEX) and operational expenditure (OPEX) over the entire lifecycle of a plant, and improve reliability. Also, directly create value by solving issues and optimizing operations throughout a supply chain, thereby enhancing productivity and profitability. -
Business innovation
Work with specific customers to create new business models that foster manufacturing excellence by such means as supplying cloud-based services that drive collaboration with their customers and suppliers and to introduce environmentally friendly manufacturing practices that are essential for a sustainable society.
Yokogawa has many years of experience in working with operational technology (OT). By combining its in-depth knowledge of plant management, operations, industries, and processes, its portfolio of automation and other information technology solutions, and its consulting expertise, the company is uniquely positioned to create new value. Working together with its customers based on the Co-innovating tomorrow (R) corporate brand slogan, Yokogawa is committed to helping them achieve the ideals expressed in its Synaptic Business Automation concept.
For more information
https://www.yokogawa.com/coin/solution/nov_2017/
About Yokogawa
Yokogawa's global network of 113 companies
spans 60 countries. Founded in 1915, the US$3.5 billion company engages
in cutting-edge research and innovation. Yokogawa is active in the
industrial automation and control (IA), test and measurement, and
aviation and other businesses segments. The IA segment plays a vital
role in a wide range of industries including oil, chemicals, natural
gas, power, iron and steel, pulp and paper, pharmaceuticals, and food.
Targeting this segment, Yokogawa helps companies maximize their profits
by offering a wide range of highly reliable products and working with
the subsidiary KBC Advanced Technologies to provide premium solutions
and services. For more information about Yokogawa, please visit www.yokogawa.com
The names of corporations, organizations, and products herein are either trademarks or registered trademarks of their respective holders.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171105005001/en/
Contact information
Yokogawa Electric Corporation
Public Relations, Integrated
Communications Center
Yokogawa-pr@cs.jp.yokogawa.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom